Abstract
Purpose of Review
This paper is intended to review common uses of phototherapy in the treatment of dermatologic disease and to highlight recent updates in the field.
Recent Findings
Phototherapy is effective in the treatment of several dermatologic conditions and offers a safe alternative to systemic treatments. Overall, limited studies on the use of phototherapy have been conducted. However, recent studies have demonstrated superior efficacy of various phototherapy options in comparison with other systemic or topical treatments for diseases such as psoriasis, vitiligo, atopic dermatitis, chronic urticaria, mycosis fungoides, pityriasis versicolor, and palmoplantar pustulosis.
Summary
Dermatologic conditions are associated with high disease burden. With multiple treatment options available, phototherapy remains an effective treatment modality in a number of these conditions and often carries a lower side effect profile and lower cost. While studies evaluating the efficacy of phototherapy alone and in combination with various systemic and non-systemic therapies do exist, insufficient studies are available to derive definitive prescriptive treatment guidelines.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Lim HW, Collins SAB, Resneck JS Jr, Bolognia JL, Hodge JA, Rohrer TA, et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(5):958–72 e2. https://doi.org/10.1016/j.jaad.
•• Vangipuram R, Feldman SR. Ultraviolet phototherapy for cutaneous diseases: a concise review. Oral Dis. 2016;22(4):253–9. https://doi.org/10.1111/odi.12366Summarizes phototherapy use in the treatment of dermatologic disease.
Lim HW, Silpa-archa N, Amadi U, Menter A, Van Voorhees AS, Lebwohl M. Phototherapy in dermatology: a call for action. J Am Acad Dermatol. 2015;72(6):1078–80. https://doi.org/10.1016/j.jaad.2015.03.017.
Bulat V, Situm M, Dediol I, Ljubicic I, Bradic L. The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll Antropol. 2011;35(Suppl 2):147–51.
Bolognia JJJ, Schaffer J. Ultraviolet therapy. 3rd ed. New York: Elsevier; 2012.
Ighani A, Partridge ACR, Shear NH, Lynde C, Gulliver WP, Sibbald C, et al. Comparison of management guidelines for moderate-to-severe plaque psoriasis: a review of phototherapy, systemic therapies, and biologic agents. J Cutan Med Surg. 2019;23(2):204–21. https://doi.org/10.1177/1203475418814234.
Mehraban S, Feily A. 308nm excimer laser in dermatology. J Lasers Med Sci. 2014;5(1):8–12.
Alshiyab D, Edwards C, Chin MF, Anstey AV. Targeted ultraviolet B phototherapy: definition, clinical indications and limitations. Clin Exp Dermatol. 2015;40(1):1–5. https://doi.org/10.1111/ced.12441.
York NR, Jacobe HT. UVA1 phototherapy: a review of mechanism and therapeutic application. Int J Dermatol. 2010;49(6):623–30. https://doi.org/10.1111/j.
• Youssef R, Ossama S, Mashaly HM, Fathy M, Safwat M, Shaker O, et al. Phototherapeutic modalities pose no significantly increased risk of oxidative damage to DNA in dark skinned individuals. Indian J Dermatol Venereol Leprol. 2016;82(6):666–72. https://doi.org/10.4103/0378-6323.186485Assesses the risk of skin cancer with phototherapy based on skin type.
• Click J, Alabaster A, Postlethwaite D, Lide W. Effect of availability of at-home phototherapy on the use of systemic medications for psoriasis. Photodermatol Photoimmunol Photomed. 2017;33(6):345–6. https://doi.org/10.1111/phpp.12349Discusses indications, benefits, and limitations to home phototherapy.
•• Howell ST, Cardwell LA, Feldman SR. A review and update of phototherapy treatment options for psoriasis. Curr Dermatol Rep. 2018;7:43–51. https://doi.org/10.1007/s13671-018-0211-3Highlights the most up-to-date research on phototherapy use in the treatment of psoriasis.
Radack KP, Farhangian ME, Anderson KL, Feldman SR. A review of the use of tanning beds as a dermatological treatment. Dermatol Ther. 2015;5(1):37–51. https://doi.org/10.1007/s13555-015-0071-8.
Bae YS, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67:459–77. https://doi.org/10.1016/j.jaad.2011.07.039.
Sokolova A, Lee A, Smith DS. The safety and efficacy of narrow band ultraviolet B treatment in dermatology: a review. Am J Clin Dermatol. 2015;16(6):501–31. https://doi.org/10.1007/s40257-015-0151-7.
•• Valejo Coelho MM, Apetato M. The dark side of the light: phototherapy adverse effects. Clin Dermatol. 2016;34(5):556–62. https://doi.org/10.1016/j.clindermatol.2016.05.005Discusses the adverse effects associated with phototherapy treatment.
Tzaneva S, Geroldinger A, Trattner H, Tanew A. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study. Br J Dermatol. 2018;178(3):682–8. https://doi.org/10.1111/bjd.16106.
Weisenseel P, Reich K, Griemberg W, Merten K, Groschel C, Gomez NN, et al. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST). J Dtsch Dermatol Ges. 2017;15(2):180–6. https://doi.org/10.1111/ddg.12837.
Reich K, Thaci D, Mrowietz U, Kamps A, Neureither M, Luger T. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis—a retrospective study (FUTURE). J Dtsch Dermatol Ges. 2009;7(7):603–11. https://doi.org/10.1111/j.1610-0387.2009.07120.x.
Bagel J, Nelson E, Keegan BR. Apremilast and narrowband ultraviolet-B combination therapy for treating moderate-to-severe plaque psoriasis. J Drugs Dermatol. 2017;16(10):957–62.
Al-Hamamy HR, Al-Mashhadani SA, Mustafa IN. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis. Int J Dermatol. 2014;53(12):1531–5. https://doi.org/10.1111/ijd.12444.
Polanska A, Gaura T, Bowszyc-Dmochowska M, Osmola-Mankowska A, Olek-Hrab K, Adamski Z, et al. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study. Int J Dermatol. 2019;58(1):108–13. https://doi.org/10.1111/ijd.14150.
Dayal S, Kaura R, Sahu P, Jain VK. Tazarotene gel with narrow-band UVB phototherapy: a synergistic combination in psoriasis. An Bras Dermatol. 2018;93(3):385–90. https://doi.org/10.1590/abd1806-4841.20186723.
Basavaraj KH, Navya MA, Rashmi R. Stress and quality of life in psoriasis: an update. Int J Dermatol. 2011;50(7):783–92. https://doi.org/10.1111/j.1365-4632.2010.04844.x.
Piaserico S, Marinello E, Dessi A, Linder MD, Coccarielli D, Peserico A. Efficacy of biofeedback and cognitive-behavioural therapy in psoriatic patientsA single-blind, randomized and controlled study with added narrow-band ultraviolet B therapy. Acta Derm Venereol. 2016;96(217):91–5. https://doi.org/10.2340/00015555-2428.
Aggarwal P, Aggarwal K, Jain VK. Tacalcitol: a useful adjunct to narrow band ultraviolet B phototherapy in psoriasis. J Dermatolog Treat. 2016;27(6):546–51. https://doi.org/10.3109/09546634.2016.1163318.
Higgins E, Ralph N, Ryan S, Koik N, Honari B, Lally A, et al. A randomised half body prospective study of low and medium dose regimens using the 308 nm excimer laser in the treatment of localised psoriasis. J Dermatolog Treat. 2017;28(1):8–13. https://doi.org/10.3109/09546634.2016.1170758.
Levin E, Debbaneh M, Malakouti M, Brown G, Wang E, Gupta R, et al. Supraerythemogenic excimer laser in combination with clobetasol spray and calcitriol ointment for the treatment of generalized plaque psoriasis: interim results of an open label pilot study. J Dermatolog Treat. 2015;26(1):16–8.
Tacastacas JD, Oyetakin-White P, Soler DC, Young A, Groft S, Honda K, et al. Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients? Photodermatol Photoimmunol Photomed. 2017;33(4):193–202. https://doi.org/10.1111/phpp.12299.
Gahalaut P, Soodan PS, Mishra N, Rastogi MK, Soodan HS, Chauhan S. Clinical efficacy of psoralen + sunlight vs. combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque-type psoriasis vulgaris: a randomized hospital-based study. Photodermatol Photoimmunol Photomed. 2014;30(6):294–301. https://doi.org/10.1111/phpp.12125.
Karn D, Kc S. Combination topical PUVAsol with methotrexate versus methotrexate in the treatment of palmoplantar psoriasis. Kathmandu Univ Med J (KUMJ). 2016;14(56):362–6.
Mou KH, Han D, Liu WL, Li P. Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo. Braz J Med Biol Res. 2016:49(8). https://doi.org/10.1590/1414-431X20165354.
Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, et al. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015;151(1):42–50. https://doi.org/10.1001/jamadermatol.2014.1875.
El-Zawahry MB, Zaki NS, Wissa MY, Saleh MA. Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo. Lasers Med Sci. 2017;32(9):1953–8. https://doi.org/10.1007/s10103-017-2290-y.
Abdelghani R, Ahmed NA, Darwish HM. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial. J Cosmet Dermatol. 2018;17(3):365–72. https://doi.org/10.1111/jocd.12397.
BinSheikhan S, Al Abadie M. Improvement in moderate to severe vitiligo using a novel combination of 308 nm excimer laser and a surgical needling technique. Clin Exp Dermatol. 2017;42(3):363–6. https://doi.org/10.1111/ced.13056.
Bapur Erduran F, Adisen E. Comparison of the efficacy of 308-nm excimer lamp monotherapy with topical tacrolimus or clobetasol 17-propionate combination therapies in localized vitiligo. Photodermatol Photoimmunol Photomed. 2016;32(5–6):247–53. https://doi.org/10.1111/phpp.12266.
Al-Shobaili HA. Treatment of vitiligo patients by excimer laser improves patients’ quality of life. J Cutan Med Surg. 2015;19(1):50–6. https://doi.org/10.2310/7750.2014.14002.
•• Khanna U, Khandpur S. What is new in narrow-band ultraviolet-B therapy for vitiligo? Indian Dermatol Online J. 2019;10(3):234–43. https://doi.org/10.4103/idoj.IDOJ_310_18Provides an overview on phototherapy for treatment of vitiligo, emphasizing the most current updates.
Dayal S, Pathak K, Sahu P, Jain VK. Narrowband UV-B phototherapy in childhood atopic dermatitis: efficacy and safety. An Bras Dermatol. 2017;92(6):801–6. https://doi.org/10.1590/abd1806-4841.20175958.
Vakeva L, Niemela S, Lauha M, Pasternack R, Hannuksela-Svahn A, Hjerppe A, et al. Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: results from an observational multicenter study. Photodermatol Photoimmunol Photomed. 2019. https://doi.org/10.1111/phpp.12479.
Maul JT, Kretschmer L, Anzengruber F, Pink A, Murer C, French LE, et al. Impact of UVA on pruritus during UVA/B phototherapy of inflammatory skin diseases: a randomized double-blind study. J Eur Acad Dermatol Venereol. 2017;31(7):1208–13. https://doi.org/10.1111/jdv.13994.
Bishnoi A, Parsad D, Vinay K, Kumaran MS. Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study. Br J Dermatol. 2017;176(1):62–70. https://doi.org/10.1111/bjd.14778.
Hoot JW, Wang L, Kho T, Akilov OE. The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides. J Dermatolog Treat. 2018;29(3):272–6. https://doi.org/10.1080/09546634.2017.1365113.
Nikolaou V, Sachlas A, Papadavid E, Economidi A, Karambidou K, Marinos L, et al. Phototherapy as a first-line treatment for early-stage mycosis fungoides: the results of a large retrospective analysis. Photodermatol Photoimmunol Photomed. 2018;34(5):307–13. https://doi.org/10.1111/phpp.12383.
Balevi A, Ustuner P, Kaksi SA, Ozdemir M. Narrow-band UV-B phototherapy: an effective and reliable treatment alternative for extensive and recurrent pityriasis versicolor. J Dermatolog Treat. 2018;29(3):252–5. https://doi.org/10.1080/09546634.2017.1364690.
Su LN, Ren J, Cheng SM, Liu JL, Ding YF, Zhu NW. UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study. Lasers Med Sci. 2017;32(8):1819–23. https://doi.org/10.1007/s10103-017-2280-0.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Steven Feldman has received research, speaking, and/or consulting support from a variety of companies including Galderma, GSK/Stiefel, Almirall, Leo Pharma, Boehringer Ingelheim, Mylan, Celgene, Pfizer, Valeant, Abbvie, Samsung, Janssen, Lilly, Menlo, Merck, Novartis, Regeneron, Sanofi, Novan, Qurient, National Biological Corporation, Caremark, Advance Medical, Sun Pharma, Suncare Research, Informa, UpToDate, and National Psoriasis Foundation. He is founder and majority owner of www.DrScore.com and founder and part owner of Causa Research, a company dedicated to enhancing patients’ adherence to treatment.
Ms. Ghamrawi and Ms. Krenitsky have no conflicts to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Photodermatology
Rights and permissions
About this article
Cite this article
Krenitsky, A., Ghamrawi, R.I. & Feldman, S.R. Phototherapy: a Review and Update of Treatment Options in Dermatology. Curr Derm Rep 9, 10–21 (2020). https://doi.org/10.1007/s13671-020-00290-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13671-020-00290-6